SCHEDULE: Vanguard Group Reports 0% Stake in Labcorp Holdings
Beneficial Ownership Amendment
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Labcorp Holdings Inc. following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 14 to Schedule 13G for Labcorp Holdings Inc. common stock.
- The filing indicates that The Vanguard Group now beneficially owns 0% of Labcorp Holdings Inc. common stock, with 0 sole or shared voting and dispositive power.
- This change is attributed to an internal realignment within The Vanguard Group, effective January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event for Labcorp Holdings Inc. as it primarily reflects an administrative change in how The Vanguard Group reports its holdings, rather than a fundamental shift in investment strategy across all Vanguard funds.
Future Outlook
No specific future outlook or guidance is provided in this administrative filing.
Industry Context
StockSavvy.ai notes that such internal realignments by large institutional investors like Vanguard are typically administrative and do not necessarily reflect a change in investment thesis for the underlying company. It's a shift in how ownership is reported by the parent entity rather than a complete divestment from all Vanguard-managed funds.
Stakeholder Impact
- Shareholders of Labcorp Holdings Inc.: Minimal direct impact, as the underlying holdings by Vanguard-managed funds may still exist, just reported differently by separate entities.
- The Vanguard Group: This represents an administrative change in their internal reporting structure for beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 01/12/1998 | SEC Release No. 34-39538, referenced for disaggregated reporting. |
| 01/12/2026 | Effective date of The Vanguard Group's internal realignment. |
| 03/13/2026 | Date of event which requires filing of this statement (beneficial ownership change). |
| 03/26/2026 | Date the Schedule 13G/A was signed by The Vanguard Group. |
Recommendation
holdThe filing indicates an administrative change in how The Vanguard Group reports its beneficial ownership, moving to a disaggregated reporting model. This does not inherently signal a change in investment thesis for Labcorp Holdings Inc. by Vanguard's broader investment vehicles. Therefore, a 'hold' recommendation is appropriate as this filing provides no new fundamental information to alter an investment decision.
Keywords
Vanguard Group, Labcorp Holdings Inc, Schedule 13G, Beneficial Ownership, Institutional Ownership, SEC Filing, Investment Management, Realignment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.